Antibody Therapies for Large B-Cell Lymphoma
Mattia Novo,1 Elisa Santambrogio,2 Pio Manlio Mirko Frascione,3,4 Delia Rota-Scalabrini,1 Umberto Vitolo1 1Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Torino, Italy; 2Hematology Unit, Santa Croce e Carle Hospital, Cuneo, Italy; 3Medical Oncology, Candiolo Canc...
Guardado en:
Autores principales: | Novo M, Santambrogio E, Frascione PMM, Rota-Scalabrini D, Vitolo U |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80698fcb410343ee8a3f82861413072a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New developments in the treatment of follicular lymphoma/ marginal zone lymphoma (according to the Congress of the American Society of Hematology – 2020)
por: Lali G. Babicheva
Publicado: (2021) - Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
por: Dipenkumar Modi, et al.
Publicado: (2021) -
Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies
por: Christina L. Parker, et al.
Publicado: (2020) -
Absolute monocyte count as a prognostic parameter in diffuse large B cell lymphoma
por: IRIGOÍN,VICTORIA, et al.
Publicado: (2019)